531399 Sigma-AldrichIRE1 Inhibitor IV, A-106
A cell permeable compound that specifically targets the RNAse domain of IRE-1 (ERN1) and blocks the activation of X-box binding protein 1 (XBP-1).
More>> A cell permeable compound that specifically targets the RNAse domain of IRE-1 (ERN1) and blocks the activation of X-box binding protein 1 (XBP-1). Less<<Sinónimos: ERN1 Inhibitor, A106
Productos recomendados
Descripción
| Replacement Information |
|---|
Tabla espec. clave
| Empirical Formula |
|---|
| C₁₁H₈O₂ |
| References | |
|---|---|
| References | Kriss, C., et al. 2012. Blood. 120, 1027. Masouleh, B. K., et al. 2014. PNAS. 111, in press. |
| Product Information | |
|---|---|
| Form | Yellowish-white powder |
| Hill Formula | C₁₁H₈O₂ |
| Chemical formula | C₁₁H₈O₂ |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | IRE1 |
| Purity | ≥98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Número de referencia | GTIN |
| 531399 | 0 |
Documentation
IRE1 Inhibitor IV, A-106 Ficha datos de seguridad (MSDS)
| Título |
|---|
IRE1 Inhibitor IV, A-106 Certificados de análisis
| Cargo | Número de lote |
|---|---|
| 531399 |
Referencias bibliográficas
| Visión general referencias |
|---|
| Kriss, C., et al. 2012. Blood. 120, 1027. Masouleh, B. K., et al. 2014. PNAS. 111, in press. |
Folleto
| Cargo |
|---|
| NPI Flyer- Epigenetics and Nuclear Function Feature |
| New Products - Antibodies, Small Molecule, Inhibitors |
Licencias necesarias e Información técnica
| Cargo |
|---|
| White Paper: Further considerations of antibody validation and usage. |


